Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Valuing gene testing in children with possible neurofibromatosis 1.

Tsang E, Birch P, Friedman JM.

Clin Genet. 2012 Dec;82(6):591-3. doi: 10.1111/j.1399-0004.2011.01801.x. Epub 2011 Nov 12.

PMID:
22014292
[PubMed - indexed for MEDLINE]
2.

Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.

Sharma P, Boyers D, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Kilonzo M, McNamee P, Mowatt G.

Health Technol Assess. 2012;16(17):1-266. doi: 10.3310/hta16170. Review.

PMID:
22469073
[PubMed - indexed for MEDLINE]
Free Article
3.

[From gene to disease; neurofibromatosis type 1].

de Goede-Bolder A, Cnossen MH, Dooijes D, van den Ouweland AM, Niermeijer MF.

Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1736-8. Review. Dutch.

PMID:
11572174
[PubMed - indexed for MEDLINE]
4.

NF1 gene and neurofibromatosis 1.

Rasmussen SA, Friedman JM.

Am J Epidemiol. 2000 Jan 1;151(1):33-40. Review.

PMID:
10625171
[PubMed - indexed for MEDLINE]
Free Article
5.

NF1 mutations and molecular testing.

Thomson SA, Fishbein L, Wallace MR.

J Child Neurol. 2002 Aug;17(8):555-61; discussion 571-2, 646-51. Review.

PMID:
12403553
[PubMed - indexed for MEDLINE]
6.

Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model.

Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, Watt I, Glanville J, Sculpher M, Kleijnen J.

Health Technol Assess. 2006 Oct;10(36):iii-iv, xi-xiii, 1-154. Review.

PMID:
17014747
[PubMed - indexed for MEDLINE]
Free Article
7.

An assessment of screening strategies for fragile X syndrome in the UK.

Pembrey ME, Barnicoat AJ, Carmichael B, Bobrow M, Turner G.

Health Technol Assess. 2001;5(7):1-95. Review.

PMID:
11262423
[PubMed - indexed for MEDLINE]
Free Article
8.

Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.

Grosse SD, Wordsworth S, Payne K.

Genet Med. 2008 Sep;10(9):648-54. doi: 10.1097GIM.0b013e3181837217. Review.

PMID:
18978674
[PubMed - indexed for MEDLINE]
9.

Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.

Main C, Moxham T, Wyatt JC, Kay J, Anderson R, Stein K.

Health Technol Assess. 2010 Oct;14(48):1-227. doi: 10.3310/hta14480. Review.

PMID:
21034668
[PubMed - indexed for MEDLINE]
Free Article
10.

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Wordsworth S, Leal J, Blair E, Legood R, Thomson K, Seller A, Taylor J, Watkins H.

Eur Heart J. 2010 Apr;31(8):926-35. doi: 10.1093/eurheartj/ehq067. Epub 2010 Mar 18. Review.

PMID:
20299350
[PubMed - indexed for MEDLINE]
Free Article
11.

The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.

Fleeman N, McLeod C, Bagust A, Beale S, Boland A, Dundar Y, Jorgensen A, Payne K, Pirmohamed M, Pushpakom S, Walley T, de Warren-Penny P, Dickson R.

Health Technol Assess. 2010 Jan;14(3):1-157, iii. doi: 10.3310/hta14030. Review.

PMID:
20031087
[PubMed - indexed for MEDLINE]
Free Article
12.

Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G.

J Genet Couns. 2007 Aug;16(4):387-407. Epub 2007 Jul 17. Review.

PMID:
17636453
[PubMed - indexed for MEDLINE]
13.

Clinical and genetic aspects of neurofibromatosis 1.

Jett K, Friedman JM.

Genet Med. 2010 Jan;12(1):1-11. doi: 10.1097/GIM.0b013e3181bf15e3. Review.

PMID:
20027112
[PubMed - indexed for MEDLINE]
14.

[Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].

Sabol Z, Kipke-Sabol L.

Lijec Vjesn. 2005 Nov-Dec;127(11-12):303-11. Review. Croatian.

PMID:
16583938
[PubMed - indexed for MEDLINE]
15.

The hunt for the neurofibromatosis gene.

Goldberg NS, Collins FS.

Arch Dermatol. 1991 Nov;127(11):1705-7. Review.

PMID:
1952978
[PubMed - indexed for MEDLINE]
16.

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.

Health Technol Assess. 2007 Sep;11(34):1-206. Review.

PMID:
17767898
[PubMed - indexed for MEDLINE]
Free Article
17.

Neurofibromatosis type 1.

Legius E, Descheemaeker MJ, Fryns JP, Van den Berghe H.

Genet Couns. 1994;5(3):225-41. Review.

PMID:
7811422
[PubMed - indexed for MEDLINE]
18.

Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.

Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, Grant A, Campbell MK, Miedyzbrodzka Z, Clarke A, Watson MS, Douglas A.

Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. Review.

PMID:
15694064
[PubMed - indexed for MEDLINE]
Free Article
19.

[Developmental manifestation in children with neurofibromatosis type 1].

Cohen R, Shuper A.

Harefuah. 2010 Jan;149(1):49-52, 61. Review. Hebrew.

PMID:
20422842
[PubMed - indexed for MEDLINE]
20.

Genetics of neurofibromatosis 1 and the NF1 gene.

Viskochil D.

J Child Neurol. 2002 Aug;17(8):562-70; discussion 571-2, 646-51. Review.

PMID:
12403554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk